Liquidia Technologies Inc (LQDA NASDAQ) stock market data APIs
$12.0687
-0(-0%)
as of July 3, 2025
Try our APIs with
free plan!
Liquidia Technologies Inc Financial Data Overview
Price chart is built with
Anychart
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Prev. Close
12.0687
Open
12.0665
High
12.3632
Low
11.8674
52 wk Range
8.26-19.41
Market Cap
1 042 M
Shares Outstanding
85 484 K
Revenue
14 144 K
EPS
-0.45
Beta
0.043
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Liquidia Technologies Inc data using free add-ons & libraries
Get Liquidia Technologies Inc Fundamental Data
Liquidia Technologies Inc Fundamental data includes:
- Net Revenue: 14 144 K
- EBITDA: -126 359 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.42
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Liquidia Technologies Inc News
New
Liquidia appoints Dana Boyle as chief accounting officer
Liquidia Corporation (NASDAQ:LQDA), a biopharmaceutical company with a current market capitalization of $1.03 billion, announced Monday that its board of directors has appointed Dana Boyle as chief ac...
Oversold Conditions For Liquidia (LQDA)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a te...
United Therapeutics EVP Mahon sells $3.14 million in UTHR stock
Paul A. Mahon, Executive Vice President and General Counsel at United Therapeutics Corp (NASDAQ:UTHR), a $12.76 billion market cap company with impressive gross profit margins of 89%, sold 11,490 sh...
Nilda Mesa, United Therapeutics director, sells $187k in stock
Nilda Mesa, a director at UNITED THERAPEUTICS (NASDAQ:UTHR), sold 645 shares of common stock on June 24, 2025. The shares were sold at a weighted average price of $289.9926, for a total transaction va...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
